[The immediate results of radiation therapy with polyradiomodification of the late stages in cancer of the oral mucosa].
Radiotherapy and polyradiomodification (metronidazole in a dose of 2.5 g/m2 and 30 min hyperthermia) result in regression of the carcinoma of the buccal mucosa and the pharynx in 72% of patients with Stages III-IV condition. No side effects of metronidazole are associated with this dose of the drug. The suggested polyradiomodification somewhat increases the normal mucosal radiosensitivity and permits a course of long-distance gamma-beam therapy in the dynamic fractionation mode.